Microsoft (Geneva)

Jean-Yves Art

Microsoft (Geneva)
Senior Director

Jean-Yves Art is Senior Director, Strategic Partnerships at Microsoft, based in Geneva. Previously, he was senior competition counsel and lead a team of lawyers who counsel business on all antitrust and regulatory aspects of Microsoft’s activities in the EMEA region. In close coordination with the Company’s headquarters in Redmond, Jean-Yves also managed regulatory proceedings, including antitrust proceeding involving the company in the region. Before joining Microsoft in 2002, Jean-Yves practiced competition law with law firms in Paris and Brussels. Jean-Yves has also worked for three years as a law clerk at the European Court of Justice. Jean-Yves was an invited professor at the College of Europe, Bruges, where he taught EU merger control, and at the University of Liège where he co-chaired a seminar on advanced topics in EU competition law. He has written extensively and is a regular speaker at conferences on EU competition law.

Auteurs associés

Microsoft (Washington)
Microsoft (Redmond)
Microsoft (Singapore)
Microsoft (Brussels)
Microsoft (Singapore)


Jean-Yves Art - Crossing Merger Control Frontiers : What are the New Borders ?
Jean-Yves Art 30 octobre 2015 Paris
Jean-Yves ART - Microsoft
Jean-Yves Art 30 septembre 2014 Paris


14521 Revue

Jean-Yves Art Interim relief in EU competition law : A matter of relevance


Les décisions constatant une infraction ou adoptant des engagements sont des outils régulièrement utilisés par les juridictions de l’Union pour mettre fin à une infraction au droit de la concurrence. Pourtant, l’adoption de mesures provisoires pourrait parfois offrir une meilleure solution. L’affaire (...)

David Schmidt, Eric Morgan de Rivery, Frank Lichtenberg, Gautier Duflos, Jean-Yves Art, Julia Holtz, Richard Gilbert Lisbon Conference - Panel IV - Intellectual property and competition - complementary policies ? The case of the software and pharmaceutical industries (14-15th January 2010)


Does patent protection restrict U.S. drug use ? The impact of patent expiration on U.S. drug prices, marketing, and utilization Franck R. LICHTENBERG*, Columbia University National Bureau of Economic Research, Faculty Fellow, Lerner Center Gautier DUFLOS*, University of Paris I, Paris (...)

Friedrich Wenzel Bulst, Jean-Yves Art, Jérôme Gstalter, Machiel Bolhuis, Maurits J. F. M. Dolmans, Mikko Välimäki, Per Hellstrom, Thomas Kramler, Ute Decker Open standards & antitrust


Contributors to this thematic study were asked to answer a question that seems simple on the surface : Do open standards promote competition ? However, this question raises a tricky and preliminary problem : how to define an “open standard” ? Written by eminent specialists, this set of articles (...)


Envoyer un message